Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

There’s More to Like About Ford Stock After the Plunge

By Chris Lau, InvestorPlace Contributor

F stock is a potential rebound play as the company pivots toward electric vehicles, starting with the Mustang Mach-E.

Coronavirus-Fighting Tech Makes iBio Stock an Interesting Play

By Chris Lau, InvestorPlace Contributor

After years trading with penny status, IBIO stock needs more than just a coronavirus vaccine to sustain its surge.

3M Offers Profits and Coronavirus Protection to Investors

By Chris Lau, InvestorPlace Contributor

3M supplies protective gear that customers need to fight off Covid-19, but that is only part of its business that will boost MMM stock.

7 Vacation Stocks to Leave at Port Now

By Chris Lau, InvestorPlace Contributor

The coronavirus outbreak sent vacation stocks like Carnival, Royal Caribbean and American Airlines to multi-year lows.

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

Load More